DDRGK1 and central nervous system cancer: The first three pathways (glycine serine and threonine metabolism, base excision repair, etc.)of DDRGK1 were enriched in the high expression group, while the remaining 17 pathways (such as inositol phosphate metabolism and glioma) were enriched in the low expression group.